NCT00112086View on ClinicalTrials.gov

OVCA-NAC-P2: Study of Chemotherapy Followed by Cytoreductive Surgery for Ovarian, Tubal and Peritoneal Cancers: JCOG0206

PHASE2CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

February 28, 2007

Study Completion Date

February 28, 2007

Conditions
Ovarian NeoplasmsFallopian Tube NeoplasmsPeritoneal Neoplasms
Interventions
DRUG

Neoadjuvant chemotherapy (Paclitaxel and Carboplatin)

Trial Locations (1)

1040045

National Cancer Center, Tsukiji, 5-1-1, Chuo-ku

All Listed Sponsors
collaborator

Ministry of Health, Labour and Welfare, Japan

OTHER_GOV

lead

Japan Clinical Oncology Group

OTHER

NCT00112086 - OVCA-NAC-P2: Study of Chemotherapy Followed by Cytoreductive Surgery for Ovarian, Tubal and Peritoneal Cancers: JCOG0206 | Biotech Hunter | Biotech Hunter